[1] Perry, C.M.; Ibbotson, T. Drugs. 2002, 62, 2221-2234. [2] Hikida, M.; Kawashima, K.; Nishiki, K.; Furukawa, Y.; Nishizawa, K.; Saito, I.; Kuwao, S. Antimicrob. Agents Chemother. 1992, 36, 481-483. [3] Yang, Y.; Bhachech, N.; Bush, K. J. Antimicrob. Chemother. 1995, 35, 75-84. [4] Nagashima, S.; Kozawa, O.; Otsuka, T.; Kohno, K.; Minamoto, M.; Yokokawa, M.; Kanamaru, M.; Uematsu, T. J. Antimicrob. Chemother. 2000, 46, 839-842. [5] Nakashima, M.; Uematsu, T.; Ueno, K.; Nagashima, S.; Inaba, H.; Nakano, M.; Kosuge, K.; Kitamura, M.; Sasaki, T. Int. J. Clin. Pharmacol. Ther. Toxicol. 1993, 31, 70-76. [6] Ikawa, K.; Morikawa, N.; Ikeda, K.; Ohge, H.; Sueda, T.; Suyama, H.; Doi, M.; Kuwabara, M. Chemotherapy. 2008, 54, 386-394. [7] Ikeda, K.; Ikawa, K.; Ikeda, A.; Nishikawa, Y.; Morikawa, N. J. Chromatogr. B. 2006, 844, 148-152. [8] Kozawa, O.; Uematsu, T.; Matsuno, H.; Niwa, M.; Takiguchi, Y.; Matsumoto, S.; Minamoto, M.; Niida, Y.; Yokokawa, M.; Nagashima, S.; Kanamaru, M. Antimicrob. Agents. Chemother. 1998, 42, 1433-1436. [9] Ikawa, K.; Morikawa, N.; Ikeda, K.; Suyama, H. J. Infect. Chemother. 2008, 14, 35-39.
[10] Guidance for Industry, Bioanalytical Method Validation (updated 2001). http://www.fda.gov/cder/guidance/index.htm [11] Xia, M.; Hang, T.J.; Zhang, F.; Li, X.M.; Xu, X.Y. J. Pharm. Biomed. Anal. 2009, 49, 937-944. |